A5018756128- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Hydrogels: synthesis, properties, applications
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Periodontal Regeneration and Treatments
- Congenital Heart Disease Studies
- Pericarditis and Cardiac Tamponade
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
- Nerve injury and regeneration
- Supramolecular Self-Assembly in Materials
- Bone Tissue Engineering Materials
- Dental Implant Techniques and Outcomes
- Cardiac Imaging and Diagnostics
- 3D Printing in Biomedical Research
- Venous Thromboembolism Diagnosis and Management
- Cellular Mechanics and Interactions
Allegheny General Hospital
2024-2025
Allegheny Health Network
2024
University of Pittsburgh
2023
University of Pittsburgh Medical Center
2023
The University of Texas Medical Branch at Galveston
2014-2018
The University of Texas at Austin
2015-2017
University of Washington
2015
Harborview Medical Center
2015
Harborview Injury Prevention and Research Center
2014
Pores are key features of natural tissues and the development scaffolds with biomimetic properties (pore structures chemical/mechanical properties) offers a route to engineer implantable biomaterials for specific niches in body. Here we report use sacrificial crystals (potassium dihydrogen phosphate or urea) that act as templates impart pores hyaluronic acid-based hydrogels. The mechanical hydrogels were analogous nervous system (in Pascal regime), investigated potassium crystal-templated...
Abstract Calcium phosphate‐based cements with enhanced regenerative potential are promising biomaterials for the healing of bone defects in procedures such as percutaneous vertebroplasty. With a view to use low load bearing applications sinus augmentation or filling extraction sites. However, inclusion certain species into cement formulations has diminish mechanical properties and thereby reduce their prospects clinical translation. Consequently, we have prepared α‐tricalcium phosphate...
Introduction Polymethylpentene (PMP) oxygenators serve as the primary oxygenator type utilized for ECMO. With number of PMP available, it has become increasingly important to determine differences among each that can lead varying metrics dysfunction. Methods This study was a retrospective, single-center analysis adult patients supported on ECMO between December 2020 2021 with including Medtronic Nautilus Smart (Minneapolis, MA), Eurosets AMG (Medolla, Italy) and Getinge Quadrox-iD Cardiohelp...
Despite historical differences in cardiogenic shock (CS) outcomes by etiology, CS etiology have yet to be described patients supported temporary mechanical circulatory support (MCS) with Impella 5.5.
ObjectivesVenoarterial extracorporeal membrane oxygenation (VA-ECMO) with concomitant percutaneous microaxial left ventricular assist device support is an emerging treatment modality for cardiogenic shock (CS). Survival outcomes by CS etiology this strategy have not been well described.MethodsThis study was a retrospective, single-center analysis of patients due to acute myocardial infarction (AMI-CS) or decompensated heart failure (ADHF-CS) supported VA-ECMO from December 2020 January...
Introduction The mobilization and ambulation of patients with severe cardiogenic shock supported peripheral veno-arterial extracorporeal membrane oxygenation (pVA-ECMO) concomitant femoral intra-aortic balloon pump (IABP) support is not well-described. This technical paper describes an protocol to prevent deconditioning in this critically ill patient population. Methods A for the pVA-ECMO IABP was created December 2022 implemented at a single center. To initiate ambulation, were initially...
VA-ECMO with concomitant Impella support (ECpella) is an emerging treatment modality for cardiogenic shock (CS). Survival outcomes by CS etiology ECpella have not been well-described.
Background: VA-ECMO with concomitant Impella support (ECpella) is an emerging treatment modality for cardiogenic shock (CS). Survival outcomes by CS etiology ECpella have not been well-described. Methods: This study was a retrospective, single-center analysis of patients due to acute myocardial infarction (AMI-CS) or decompensated heart failure (ADHF-CS) supported from December 2020 January 2023. Primary included 90-day survival post-discharge and destination after support. Secondary...
Modi, Shan; Pachmann, Xenia; Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Souter, Michael; Vavilala, Monica Author Information